Telesta Therapeutics Inc. is a Canadian biotechnology company, founded in 1979, that focuses on acquiring and developing transformational therapeutics for the treatment of serious human diseases, including cancer, immune diseases, and targeted rare diseases. The company attracted a significant $28.60M in its Venture Round investment on 20th August 2015, with participation from prominent investors such as Boxer Capital, Consonance Capital, and Moega Funds. Notably, Prometic Life Sciences Inc. acquired Telesta on October 31, 2016. With a focus on biotechnology, manufacturing, and pharmaceuticals, the company exemplifies potential in addressing critical medical needs and producing impactful solutions for various ailments.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $28.60M | 3 |
|
20 Aug 2015 |
No recent news or press coverage available for Telesta Therapeutics Inc..
We care about your data, and we'd love to use cookies make your experience better.
